Articles published by GlobeNewswire
Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia
June 18, 2025
From Biogen Inc.
Via GlobeNewswire
Tickers
BIIB
Via GlobeNewswire
Via GlobeNewswire
Via GlobeNewswire
Tickers
CLMB
From OTC Markets
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.